Americans’ Willingness to Get COVID-19 Vaccines Declines, Survey Finds
A survey found that 44% of Americans are likely to get a yearly COVID-19 vaccine if recommended by the CDC, a drop from 52% just eight months earlier.
Category: US Pharmaceuticals
US Pharmaceuticals
Latest
US Pharmaceuticals
Latest
CDC Recommends Updated COVID-19 and Flu Vaccines for Fall and Winter
The CDC advises everyone 6 months and older to receive the updated 2024-2025 COVID-19 and flu vaccines to protect against severe respiratory illnesses this upcoming season.
US Pharmaceuticals
Latest
FDA Expands Approval of Arexvy for Adults Age 50-59
GlaxoSmithKline's RSV vaccine Arexvy is now available for at-risk adults age 50-59 in addition to those age 60 and older.
COVID-19 Vaccination Boosts Survival Odds for Heart Failure Patients
Research presented at the ESC’s annual congress shows a significant survival benefit for heart failure patients who receive COVID-19 vaccinations.
Read More
Can Zinc Really Shorten a Cold? New Review Revisits Zinc’s Cold-Fighting Claims
A Cochrane review examines multiple studies to evaluate the effectiveness of zinc supplements in preventing and treating the common cold.
Read More
Faster Naltrexone Protocol Improves Opioid Treatment Success
Starting extended-release naltrexone within five to seven days of seeking treatment improves success rates for opioid addiction compared to the standard 10-15 days, but requires closer medical supervision.
Read More
Most Pregnant Women Open to RSV Vaccine to Protect Infants, Survey Finds
A nationwide survey revealed that 54% of individuals who are pregnant or trying to become pregnant are interested in the RSV vaccine.
Read More
1 in 4 Antibiotic Prescriptions Wasted on Unresponsive Patient Conditions, Including COVID-19
A five-year trend study shows a rebound in inappropriate use of antibiotics after an early pandemic dip.
Read More
Baxter Expands US Pharma Portfolio
Baxter has expanded its US pharmaceuticals portfolio by launching five injectable drugs, including Vancomycin to treat infections of methicillin-resistant staphylococci.
Read More
US Hospitals Slow to Adopt Newer Antibiotics for Highly Resistant Infections
Hospitals still treated over 40% of patients battling highly resistant infections exclusively with the older, generic agents, an NIH study finds.
Read More
Ivacaftor Safe in CF Infants Aged 1 to 4 Months
A phase 3 clinical trial, ivacaftor (Kalydeco, Vertex Pharma) was generally safe to administer to infants aged 1-month to <4-months old, according to research published in Journal of Cystic Fibrosis.
Read More
Generative AI Model Designs New Superbug-fighting Antibiotics
Researchers have invented a new artificial intelligence model that can design billions of new antibiotic molecules that are inexpensive and easy to build in the laboratory.Â
Read More
COVID-19 OTC Choices Should Consider Patient’s Full Risk-Benefit Profile
CDC guidance states that most people with COVID-19 can recover at home with over-the-counter medications. But Florida Atlantic University researchers say it’s more complicated.
Read More
US News Reveals the 2024 Best OTC Cough, Cold, and Allergy Medicines
The second annual Best OTC Medicine & Health Products rankings by US News & World Report offer consumers guidance in selecting the most effective over-the-counter remedies, including cough, cold, and allergy medicines.
Read More
FDA Authorizes Pemgarda for COVID-19 Prevention
Invivyd’s Pemgarda receives FDA authorization for COVID-19 prevention in immunocompromised individuals. Explore the significance of this breakthrough therapy and its potential to safeguard vulnerable populations against the virus.
Read More